Zeto

What Zeto does

Zeto, Inc. is a privately held medical technology company that develops wireless, dry-electrode EEG headsets and a HIPAA-compliant cloud platform for hospitals, outpatient neurology practices, and clinical research sites. The company's core technology pairs proprietary active dry-electrode hardware with signal pre-amplification at the scalp (CMRR above 130dB) and a cloud platform that supports remote viewing, multi-site multi-user data management, and AI-powered seizure detection. Its product portfolio comprises the Zeto ONE headset for critical care settings (ICU, emergency departments, EMS) and the New Wave headset for outpatient and home use, both delivering full 10-20 montage coverage with average setup times under five minutes versus 20-40 minutes for conventional EEG systems.

The company generates revenue through direct enterprise sales of FDA-cleared hardware combined with subscription-based cloud platform access, AI seizure detection (NeuroPulse), and AI-assisted EEG reporting (NeuroNotis), with optional board-certified neurologist interpretation services as an add-on. Its go-to-market motion is enterprise field sales targeting hospital systems, neurology practices, and academic medical centers, supported by a clinical trial sponsorship program running annually across the US, UK, and Australia that builds clinical evidence and institutional relationships. The customer base spans solo neurology practices, mid-market multispecialty clinics, and enterprise health systems including UPMC Children's Hospital of Pittsburgh, Huntsville Memorial Hospital, Ukiah Adventist Hospital, and MD Anderson, with 200+ US healthcare facilities using the platform.

Zeto has secured three FDA 510(k) clearances and built its AI capability through a partnership with encevis (Austrian Institute of Technology), whose seizure detection model is trained on more than 21,400 hours of EEG data from 800+ patients. The company is backed by venture capital with cumulative disclosed funding of approximately $54 million, anchored by a $31 million Series B in January 2025 led by MindWorks Capital. Leadership includes founder and CEO Aswin Gunasekar, CTO Gabor Braun, CFO Neway Redia, and Chief Sales Officer Florian Strelzyk. Active research collaborations extend across multiple US institutions (Vanderbilt, UT Austin, Baylor, UNC, VA Charleston) and into underserved markets including Nigeria and Zambia.

Name

Zeto

Legal name

Zeto, Inc.

Website

https://zeto-inc.com

Company type

Private

Founded year

2019

Operating status

Operating

Headcount range

11–50 employees

Short description

Zeto is a privately held medical technology company that sells FDA-cleared wireless dry-electrode EEG headsets and a HIPAA-compliant cloud platform to hospitals, neurology practices, and clinical research sites, supplemented by AI-powered seizure detection and reporting tools.

Ownership category

akta.pro rank

Product category

Neurology Diagnostic Devices

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)

SIC

Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Neurological Monitoring (EEG, Seizure/Sleep/Neuro Wearables) (HLAHACAE)

akta.pro secondary industry

Epilepsy & Seizure Disorders (HLAKAIAB)

Keywords

• EEG medical devices
• Neurology diagnostic equipment
• Dry electrode headsets
• Seizure detection software
• Cloud EEG platform

Headquarters

HQ city

Santa Clara

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Personnel, Marketing or Sales, Supply Chain, Operations

Revenue model

1. Hardware Sales - EEG Headsets: Sale of FDA-cleared EEG hardware devices including Zeto ONE and New Wave headsets to healthcare facilities, hospitals, and outpatient clinics.
2. Cloud Platform Subscription: Cloud-based EEG data access, storage, and analysis platform provided as part of service agreements. Includes remote viewing, video EEG, and data management capabilities.
3. AI-Powered Software Analysis: NeuroPulse seizure detection and NeuroNotis AI-enabled reporting services provided as add-on capabilities within existing service agreements.
4. EEG Reading Services: Optional EEG interpretation services by board-certified neurologists available as an add-on service.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels9 records

Core offering

Zeto designs and sells FDA-cleared wireless, gel-free, dry-electrode EEG headsets (Zeto ONE for ICU/ED/EMS and New Wave for outpatient and home use) and delivers the recordings through a HIPAA-compliant cloud platform that includes live video EEG viewing and AI-powered seizure detection. The company also offers NeuroNotis AI-enabled reporting reviewed by Stratus Registered EEG Technologists and optional EEG interpretation services by board-certified neurologists.

Differentiator

Problem solved

Functional benefit

Brands

• Zeto ONE: Second-generation EEG system designed for critical care settings including ICU, emergency departments, and EMS vehicles with extended recording capabilities.
• New Wave
• NeuroPulse
• NeuroNotis

Products and services

• Zeto ONE EEG Headset FDA-cleared wireless EEG headset for critical care settings (ICU, ED, EMS), providing full 10-20 montage EEG with extended recording capability, gel-free dry electrodes, sub-5-minute setup, and cloud-based remote viewing for hospitals and emergency services.
• New Wave EEG Headset FDA-cleared compact outpatient EEG system for neurology practices, clinics, and home-based care, supporting routine EEG studies up to 2.5 hours with 21 dry electrodes, technician-free application, and remote access through the Zeto cloud platform.
• NeuroPulse AI Seizure Detection AI-powered seizure burden and Status Epilepticus detection capability that analyzes full 10-20 EEG recordings in real time to alert clinicians of seizure activity in critical care, emergency, and outpatient settings.
• NeuroNotis Report AI-enabled EEG report service that combines automated seizure detection with human review by Stratus Registered EEG Technologists, producing a clinical report approximately 15 minutes after the first hour of recording for hospitals and neurology practices.
• Zeto Cloud Platform HIPAA-compliant cloud platform that delivers remote access to live video EEG, multi-site multi-user collaboration, data management, archiving, and integrates AI seizure detection and reporting for Zeto hardware customers.

Quantifiable outcome

• Setup time reduced from 20-40 minutes to under 5 minutes
• +5 more outcomes

Named customers6 records

Segments5 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

AI capability4 records

Feature7 records

Partnerships

Three partnerships are on record, tiered core and minor.

• Stratus Registered EEG TechnologistscoreStrategic or Co-development Partner · 16 April 2026Human review partnership for NeuroNotis AI-enabled EEG reports. Stratus R. EEG T. provides technical review of AI-generated reports to address clinical decision-making uncertainty when relying solely on AI algorithms. Results delivered approximately 15 minutes after first hour of recording at no additional cost within existing service agreements.
• MD Anderson Cancer Center - Neurology DepartmentminorStrategic or Co-development Partner · 18 August 2025Research collaboration on brain-computer interface project connecting EEG technology with music therapy. Dr. Mei Rui at MD Anderson encouraged expansion of the system to detect and map multiple brain regions and frequency bandwidths to musical motifs for therapeutic purposes.
• encevis (Austrian Institute of Technology)coreTechnology or Integration · 2 April 2025Collaboration to integrate NeuroPulse AI-powered seizure burden and Status Epilepticus detection capability into Zeto's full 10-20 EEG platform. The encevis AI model was trained on over 21,400 hours of EEG recordings from more than 800 patients and validated on an independent dataset of 81 patients. This addresses critical unmet need as up to one-third of neurological critical care and emergency department patients are at risk for seizures.

Scale indicators7 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Natus Medical: One of the largest legacy EEG hardware and neurology diagnostics vendors globally. Directly competes with Zeto across hospital EEG, ICU monitoring, and outpatient neurology workflows, with established reimbursement and procurement relationships that Zeto is working to displace.
• Compumedics: Australia-based EEG and sleep diagnostics company offering hospital-grade EEG systems, ambulatory EEG, and cloud review platforms. Competes head-on with Zeto's hardware-plus-cloud strategy in neurology and ICU/critical-care EEG.
• Cadwell Industries: US-based neurodiagnostic equipment maker with a long-standing hospital and outpatient EEG installed base. Competes directly with Zeto in routine and ambulatory EEG, with comparable clinical customer segments.
• Wave Neuroscience: EEG-focused company developing clinical and consumer EEG platforms, including qEEG/MEG-adjacent offerings. Competes with Zeto at the intersection of clinical EEG hardware, AI analytics, and neurotechnology applications.
• Brain Products: Germany-based maker of research- and clinical-grade EEG systems widely used in academic and clinical research settings. Competes with Zeto in the clinical-research segment Zeto targets via its sponsorship program and academic medical center sales.
• ANT Neuro: Netherlands-based EEG and neuromodulation company with hospital and research-oriented EEG products. Comparable to Zeto in its mix of clinical and research customers and its focus on full-montage EEG systems.

Emerging players

• Emotiv: Consumer and prosumer EEG headset maker with growing developer/research presence. Adjacent to Zeto via dry-electrode EEG hardware, though Emotiv primarily targets B2C, B2B research, and brain-computer-interface use cases rather than FDA-cleared clinical workflows.
• Cumulus Neuroscience: Clinical-stage EEG platform company focused on at-home EEG assessments for CNS clinical trials. Comparable to Zeto in applying EEG to clinical research and outpatient use cases, with overlapping neurology and CNS trial customers.

Broad incumbents

• Ceribell: Point-of-care EEG company focused on ICU seizure detection with an FDA-cleared rapid-EEG headset and cloud platform. Directly competes with Zeto ONE in the same ICU and ED use case and has raised significantly more capital at a much larger scale.
• iRhythm Technologies: Public ambulatory cardiac monitoring company with an AI-enabled wearable + cloud platform business model. Comparable to Zeto in its mix of FDA-cleared hardware, AI diagnostic algorithms, and recurring service revenue per patient test.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

• Xx.com/Zeto_inc
• LinkedInlinkedin.com/company/zeto-incorporated

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds7 records

Investors9 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Zeto